Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2007Cancer Research

Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAhmed O. KasebThe University of Texas MD Anderson Cancer CenterKCKannagi ChinnakannuDCDi ChenChina Rehabilitation Research Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kaseb et al. (2007) studied this question.

synapsesocial.com/papers/6ab8b5887f6ad359161378ebhttps://doi.org/10.1158/0008-5472.can-07-1483
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone2003 · 236 citations
  2. 2Androgen receptors in prostate cancer.2002 · 248 citations
  3. 3Metastatic patterns of prostatic cancer: Correlation between sites and number of organs involved1984 · 252 citations